A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients

BACKGROUND: Multiple sclerosis (MS) is a chronic disease characterized by demyelination, glial activation and axonal degeneration in the central nervous system. At the present, there is no certain remedy for this disease. However, available therapies often attenuate disease progress. METHODS: This s...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Transl Med
Главные авторы: Mazdeh, Mehrdokht, Kargar Monhaser, Shahriar, Taheri, Mohammad, Ghafouri-Fard, Soudeh
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2019
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451934/
https://ncbi.nlm.nih.gov/pubmed/30957197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-019-0228-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы